News & Analysis on Pharmaceutical Technology & Manufacturing
Medivir - Linda Basse
By Maggie Lynch
- Last updated on
Linda Basse was appointed chief medical officer at Medivir, following her 18 years of working in drug development and medical marketing. Her experience lies in the development of oncology drugs, managing and advising companies in development such as Abbott Laboratories, Nycomed, and Novo Nordisk.
She previously served as medical director at Zealand Pharma, a biotech focused on developing peptide-based medicines. She also worked as medical director at Genmab and contributed to the approval of datatumumab
CEO of Medivir, Christine Lind said the Basse has a “strong track record” and will be “responsible for the clinical strategy and development of our pipeline.”